DCM Shriram Industries Limited (NSE:DCMSRIND)
India · Delayed Price · Currency is INR | Market Cap | 14.89B |
| Revenue (ttm) | 20.52B |
| Net Income (ttm) | 1.01B |
| Shares Out | n/a |
| EPS (ttm) | 11.66 |
| PE Ratio | 14.68 |
| Forward PE | n/a |
| Dividend | 2.00 (1.22%) |
| Ex-Dividend Date | Apr 4, 2025 |
| Volume | 135,677 |
| Average Volume | 107,480 |
| Open | 172.62 |
| Previous Close | 171.25 |
| Day's Range | 170.05 - 174.80 |
| 52-Week Range | 142.11 - 214.90 |
| Beta | 0.41 |
| RSI | 54.69 |
| Earnings Date | Aug 12, 2025 |
About Blueprint Medicines
DCM Shriram Industries Limited engages in the production and sale of sugar, alcohol, power, chemicals, industrial fibers, and defence-related products in India, Europe, China, Mexico, and internationally. It operates through three segments: Sugar; Industrial Fibres and Related Products; and Chemicals. The company offers refined sugar, sugar cubes, fine sugar, and refined sugar sachets to pharmaceutical, food, home, hotels, airlines, railways, hospitals, restaurants, clubs, fast food chains, caterers, beverages, dairy products, and confectionery... [Read more]
Financial Performance
In 2024, DCM Shriram Industries's revenue was 20.52 billion, a decrease of -1.50% compared to the previous year's 20.83 billion. Earnings were 1.01 billion, a decrease of -12.07%.
Financial StatementsNews
DCM Shriram Industries board announces Rs 2 per share interim dividend for FY25
DCM Shriram Industries has announced an interim dividend of ₹2 per equity share (100%) for the financial year 2024-25. The decision was taken during the Board of Directors meeting held on March 28, 20...